RESMED INC (RMD) Fundamental Analysis & Valuation

NYSE:RMD • US7611521078

240.2 USD
-6.91 (-2.8%)
Last: Mar 11, 2026, 03:58 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This RMD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

Overall RMD gets a fundamental rating of 7 out of 10. We evaluated RMD against 184 industry peers in the Health Care Equipment & Supplies industry. RMD gets an excellent profitability rating and is at the same time showing great financial health properties. RMD has a correct valuation and a medium growth rate. Finally RMD also has an excellent dividend rating. With these ratings, RMD could be worth investigating further for dividend and quality investing!.


Dividend Valuation Growth Profitability Health

9

1. RMD Profitability Analysis

1.1 Basic Checks

  • RMD had positive earnings in the past year.
  • In the past year RMD had a positive cash flow from operations.
  • Each year in the past 5 years RMD has been profitable.
  • In the past 5 years RMD always reported a positive cash flow from operatings.
RMD Yearly Net Income VS EBIT VS OCF VS FCFRMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 17.47%, RMD belongs to the top of the industry, outperforming 97.28% of the companies in the same industry.
  • With an excellent Return On Equity value of 23.51%, RMD belongs to the best of the industry, outperforming 96.20% of the companies in the same industry.
  • The Return On Invested Capital of RMD (20.84%) is better than 97.83% of its industry peers.
  • RMD had an Average Return On Invested Capital over the past 3 years of 18.06%. This is significantly above the industry average of 9.15%.
  • The last Return On Invested Capital (20.84%) for RMD is above the 3 year average (18.06%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 17.47%
ROE 23.51%
ROIC 20.84%
ROA(3y)15.1%
ROA(5y)14.12%
ROE(3y)22.06%
ROE(5y)21.17%
ROIC(3y)18.06%
ROIC(5y)18.51%
RMD Yearly ROA, ROE, ROICRMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • RMD has a better Profit Margin (27.53%) than 97.28% of its industry peers.
  • In the last couple of years the Profit Margin of RMD has grown nicely.
  • The Operating Margin of RMD (34.11%) is better than 99.46% of its industry peers.
  • In the last couple of years the Operating Margin of RMD has grown nicely.
  • RMD has a better Gross Margin (60.85%) than 62.50% of its industry peers.
  • In the last couple of years the Gross Margin of RMD has remained more or less at the same level.
Industry RankSector Rank
OM 34.11%
PM (TTM) 27.53%
GM 60.85%
OM growth 3Y5.43%
OM growth 5Y3.67%
PM growth 3Y7.71%
PM growth 5Y5.3%
GM growth 3Y1.6%
GM growth 5Y0.42%
RMD Yearly Profit, Operating, Gross MarginsRMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. RMD Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), RMD is creating value.
  • Compared to 1 year ago, RMD has less shares outstanding
  • Compared to 5 years ago, RMD has more shares outstanding
  • RMD has a better debt/assets ratio than last year.
RMD Yearly Shares OutstandingRMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
RMD Yearly Total Debt VS Total AssetsRMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • RMD has an Altman-Z score of 12.70. This indicates that RMD is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 12.70, RMD belongs to the best of the industry, outperforming 94.02% of the companies in the same industry.
  • RMD has a debt to FCF ratio of 0.37. This is a very positive value and a sign of high solvency as it would only need 0.37 years to pay back of all of its debts.
  • RMD's Debt to FCF ratio of 0.37 is amongst the best of the industry. RMD outperforms 91.30% of its industry peers.
  • RMD has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • RMD has a better Debt to Equity ratio (0.06) than 67.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.37
Altman-Z 12.7
ROIC/WACC2.12
WACC9.83%
RMD Yearly LT Debt VS Equity VS FCFRMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

  • RMD has a Current Ratio of 3.06. This indicates that RMD is financially healthy and has no problem in meeting its short term obligations.
  • RMD's Current ratio of 3.06 is in line compared to the rest of the industry. RMD outperforms 56.52% of its industry peers.
  • A Quick Ratio of 2.32 indicates that RMD has no problem at all paying its short term obligations.
  • RMD has a Quick ratio (2.32) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.06
Quick Ratio 2.32
RMD Yearly Current Assets VS Current LiabilitesRMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. RMD Growth Analysis

3.1 Past

  • RMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.29%, which is quite good.
  • Measured over the past years, RMD shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.94% on average per year.
  • The Revenue has grown by 9.57% in the past year. This is quite good.
  • Measured over the past years, RMD shows a quite strong growth in Revenue. The Revenue has been growing by 11.72% on average per year.
EPS 1Y (TTM)16.29%
EPS 3Y18.15%
EPS 5Y14.94%
EPS Q2Q%15.64%
Revenue 1Y (TTM)9.57%
Revenue growth 3Y12.88%
Revenue growth 5Y11.72%
Sales Q2Q%10.98%

3.2 Future

  • RMD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.77% yearly.
  • RMD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.40% yearly.
EPS Next Y16.4%
EPS Next 2Y13.39%
EPS Next 3Y11.65%
EPS Next 5Y10.77%
Revenue Next Year10.03%
Revenue Next 2Y8.69%
Revenue Next 3Y7.93%
Revenue Next 5Y8.4%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
RMD Yearly Revenue VS EstimatesRMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
RMD Yearly EPS VS EstimatesRMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

5

4. RMD Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 23.37, RMD is valued on the expensive side.
  • Based on the Price/Earnings ratio, RMD is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
  • RMD is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.25, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 19.56, which indicates a rather expensive current valuation of RMD.
  • Based on the Price/Forward Earnings ratio, RMD is valued a bit cheaper than 78.26% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.39. RMD is around the same levels.
Industry RankSector Rank
PE 23.37
Fwd PE 19.56
RMD Price Earnings VS Forward Price EarningsRMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 76.63% of the companies in the same industry are more expensive than RMD, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, RMD is valued cheaper than 88.59% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.7
EV/EBITDA 17.23
RMD Per share dataRMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of RMD may justify a higher PE ratio.
PEG (NY)1.42
PEG (5Y)1.56
EPS Next 2Y13.39%
EPS Next 3Y11.65%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. RMD Dividend Analysis

5.1 Amount

  • RMD has a yearly dividend return of 0.94%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.21, RMD pays a better dividend. On top of this RMD pays more dividend than 91.85% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, RMD's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.94%

5.2 History

  • The dividend of RMD is nicely growing with an annual growth rate of 6.33%!
  • RMD has paid a dividend for at least 10 years, which is a reliable track record.
  • RMD has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)6.33%
Div Incr Years12
Div Non Decr Years12
RMD Yearly Dividends per shareRMD Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • RMD pays out 22.25% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of RMD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP22.25%
EPS Next 2Y13.39%
EPS Next 3Y11.65%
RMD Yearly Income VS Free CF VS DividendRMD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
RMD Dividend Payout.RMD Dividend Payout, showing the Payout Ratio.RMD Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

RMD Fundamentals: All Metrics, Ratios and Statistics

RESMED INC

NYSE:RMD (3/11/2026, 3:58:59 PM)

240.2

-6.91 (-2.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-29
Earnings (Next)04-21
Inst Owners68.21%
Inst Owner Change5.84%
Ins Owners0.49%
Ins Owner Change-0.27%
Market Cap34.99B
Revenue(TTM)5.40B
Net Income(TTM)1.49B
Analysts74.4
Price Target303.44 (26.33%)
Short Float %6.97%
Short Ratio9.39
Dividend
Industry RankSector Rank
Dividend Yield 0.94%
Yearly Dividend2.12
Dividend Growth(5Y)6.33%
DP22.25%
Div Incr Years12
Div Non Decr Years12
Ex-Date02-12
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.49%
Min EPS beat(2)-1.16%
Max EPS beat(2)2.15%
EPS beat(4)2
Avg EPS beat(4)0.54%
Min EPS beat(4)-1.16%
Max EPS beat(4)2.15%
EPS beat(8)5
Avg EPS beat(8)2.85%
EPS beat(12)8
Avg EPS beat(12)2.12%
EPS beat(16)10
Avg EPS beat(16)1.2%
Revenue beat(2)1
Avg Revenue beat(2)0.14%
Min Revenue beat(2)-0.62%
Max Revenue beat(2)0.91%
Revenue beat(4)2
Avg Revenue beat(4)0.12%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)0.91%
Revenue beat(8)5
Avg Revenue beat(8)0.55%
Revenue beat(12)7
Avg Revenue beat(12)0.61%
Revenue beat(16)8
Avg Revenue beat(16)0.24%
PT rev (1m)-0.03%
PT rev (3m)1.11%
EPS NQ rev (1m)0.05%
EPS NQ rev (3m)1.22%
EPS NY rev (1m)0%
EPS NY rev (3m)1.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.98%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.73%
Valuation
Industry RankSector Rank
PE 23.37
Fwd PE 19.56
P/S 6.48
P/FCF 19.7
P/OCF 18.28
P/B 5.54
P/tB 12.29
EV/EBITDA 17.23
EPS(TTM)10.28
EY4.28%
EPS(NY)12.28
Fwd EY5.11%
FCF(TTM)12.2
FCFY5.08%
OCF(TTM)13.14
OCFY5.47%
SpS37.05
BVpS43.39
TBVpS19.54
PEG (NY)1.42
PEG (5Y)1.56
Graham Number100.18
Profitability
Industry RankSector Rank
ROA 17.47%
ROE 23.51%
ROCE 25.38%
ROIC 20.84%
ROICexc 25.9%
ROICexgc 63.96%
OM 34.11%
PM (TTM) 27.53%
GM 60.85%
FCFM 32.91%
ROA(3y)15.1%
ROA(5y)14.12%
ROE(3y)22.06%
ROE(5y)21.17%
ROIC(3y)18.06%
ROIC(5y)18.51%
ROICexc(3y)19.85%
ROICexc(5y)20.16%
ROICexgc(3y)47.68%
ROICexgc(5y)50.03%
ROCE(3y)22%
ROCE(5y)22.55%
ROICexgc growth 3Y8.61%
ROICexgc growth 5Y0.25%
ROICexc growth 3Y5.42%
ROICexc growth 5Y4.3%
OM growth 3Y5.43%
OM growth 5Y3.67%
PM growth 3Y7.71%
PM growth 5Y5.3%
GM growth 3Y1.6%
GM growth 5Y0.42%
F-Score6
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.37
Debt/EBITDA 0.2
Cap/Depr 67.31%
Cap/Sales 2.55%
Interest Coverage 53.22
Cash Conversion 93.57%
Profit Quality 119.57%
Current Ratio 3.06
Quick Ratio 2.32
Altman-Z 12.7
F-Score6
WACC9.83%
ROIC/WACC2.12
Cap/Depr(3y)65.59%
Cap/Depr(5y)70.36%
Cap/Sales(3y)2.53%
Cap/Sales(5y)3.12%
Profit Quality(3y)102.06%
Profit Quality(5y)92.37%
High Growth Momentum
Growth
EPS 1Y (TTM)16.29%
EPS 3Y18.15%
EPS 5Y14.94%
EPS Q2Q%15.64%
EPS Next Y16.4%
EPS Next 2Y13.39%
EPS Next 3Y11.65%
EPS Next 5Y10.77%
Revenue 1Y (TTM)9.57%
Revenue growth 3Y12.88%
Revenue growth 5Y11.72%
Sales Q2Q%10.98%
Revenue Next Year10.03%
Revenue Next 2Y8.69%
Revenue Next 3Y7.93%
Revenue Next 5Y8.4%
EBIT growth 1Y18%
EBIT growth 3Y19.01%
EBIT growth 5Y15.82%
EBIT Next Year26.45%
EBIT Next 3Y13.99%
EBIT Next 5Y11.01%
FCF growth 1Y88.25%
FCF growth 3Y103.78%
FCF growth 5Y18.84%
OCF growth 1Y77.41%
OCF growth 3Y70.86%
OCF growth 5Y16.9%

RESMED INC / RMD FAQ

What is the ChartMill fundamental rating of RESMED INC (RMD) stock?

ChartMill assigns a fundamental rating of 7 / 10 to RMD.


Can you provide the valuation status for RESMED INC?

ChartMill assigns a valuation rating of 5 / 10 to RESMED INC (RMD). This can be considered as Fairly Valued.


What is the profitability of RMD stock?

RESMED INC (RMD) has a profitability rating of 9 / 10.


Can you provide the PE and PB ratios for RMD stock?

The Price/Earnings (PE) ratio for RESMED INC (RMD) is 23.37 and the Price/Book (PB) ratio is 5.54.


What is the financial health of RESMED INC (RMD) stock?

The financial health rating of RESMED INC (RMD) is 8 / 10.